Skin & Subcutaneous Tissue

Cellulitis vs stasis dermatitis: distinguishing features

Clinical Overview and When to Suspect Cellulitis vs Stasis Dermatitis

— Up to 30% of patients admitted for "cellulitis" actually have pseudocellulitis (stasis dermatitis, lipodermatosclerosis, contact dermatitis, DVT, gout).

— Cellulitis is a bacterial infection of the dermis and subcutaneous tissue (typically β-hemolytic strep, less often S. aureus).

— Stasis dermatitis is an inflammatory, non-infectious condition from chronic venous hypertension causing capillary leak, fibrin cuffing, and hemosiderin deposition.

— Acute unilateral warmth, erythema, tenderness with fever, leukocytosis, or rapid spread

— Identifiable portal of entry (tinea pedis interdigital, ulcer, trauma, lymphedema)

— Risk factors: obesity, diabetes, prior cellulitis, venous insufficiency, IV drug use

— Bilateral (or asymmetric but bilateral) lower-leg erythema, chronic course (weeks–months)

— Pruritus rather than pain, medial malleolus predominance

— Hemosiderin (brown) staining, varicosities, pitting edema, dependent worsening

— Patient is afebrile, well-appearing, no leukocytosis

Core problem: Lower-extremity erythema is one of the most common reasons for primary care visits and ED referrals, and misdiagnosis of stasis dermatitis as cellulitis drives substantial unnecessary antibiotic use, hospitalization, and C. difficile risk.

When to suspect cellulitis:

When to suspect stasis dermatitis:

Step 3 management: In an ambulatory patient with bilateral lower-leg erythema, no fever, no leukocytosis, and chronic edema, the answer is almost never "start cephalexin" — it's compression, topical steroids, and leg elevation. Reflexively prescribing antibiotics for warm red legs is a recurring Step 3 wrong-answer trap.

Health-systems angle: Reducing pseudocellulitis admissions is a documented value-based care metric; dermatology e-consults and structured exam pathways reduce inappropriate IV antibiotics by ~50%.

Presentation Patterns and Key History

— Tempo: hours-to-days of progressive erythema; patient can often point to when it started

— Symptoms: pain > pruritus, fever, chills, malaise; may report red streaking (lymphangitis)

— Trigger: recent skin break — tinea pedis, insect bite, IV catheter, ulcer, eczema, surgical wound, animal/human bite

— Laterality: almost always unilateral; bilateral simultaneous cellulitis is rare and should prompt rethinking

— Risk factors: lymphedema (post-mastectomy, post–lymph node dissection), chronic venous insufficiency, obesity (BMI >30 triples risk), diabetes, prior cellulitis (recurrence rate ~30% within 3 years), IVDU, immunosuppression

— Tempo: weeks to months, waxing/waning, worse at end of day and with prolonged standing

— Symptoms: pruritus, aching, heaviness; minimal acute tenderness; relief with elevation

— Background: chronic venous insufficiency, prior DVT, varicose veins, CHF, obesity, pregnancy history, occupations involving prolonged standing

— Laterality: bilateral (may be asymmetric); the "more swollen" leg can look acutely inflamed and fool clinicians

— Recurrent "cellulitis" diagnoses that resolve without antibiotics is a major clue for stasis dermatitis

Cellulitis history:

Stasis dermatitis history:

Key distinction: Ask "Is the other leg also red?" and "Does elevation make it better?" Bilateral involvement + improvement with elevation is stasis dermatitis until proven otherwise. Cellulitis does not improve with leg elevation alone.

Board pearl: A patient with recurrent admissions for "bilateral cellulitis" who keeps getting antibiotics is the classic stasis dermatitis stem. The right next step is compression therapy and topical steroids, not another course of cephalexin.

Red flags requiring deeper history: rapidly expanding margin (>2 cm/hr), pain out of proportion, crepitus, bullae, anesthesia over the lesion → think necrotizing fasciitis, not simple cellulitis.

Physical Exam Findings and Bedside Assessment

— Erythema: poorly demarcated, warm, tender, unilateral

— Edge: typically flat (sharp raised border suggests erysipelas — superficial dermal/lymphatic strep infection)

— Skin: smooth, taut, sometimes peau d'orange; may have lymphangitic streaks toward regional nodes

— Bullae, necrosis, crepitus, or violaceous discoloration = severe or necrotizing infection

— Systemic: fever, tachycardia; check for SIRS/sepsis criteria

— Portal of entry hunt: always examine interdigital web spaces for tinea pedis (most common gateway) and inspect for ulcers, IVDU track marks

— Distribution: bilateral, medial gaiter area (medial malleolus and lower shin)

— Color: dull red-brown, hemosiderin (rust/brown) staining, not bright fiery red

— Texture: dry, scaly, lichenified, weeping when acute; may have eczematous plaques

— Associated: varicose veins, pitting edema (improves overnight), atrophie blanche (white scar plaques), lipodermatosclerosis ("inverted champagne bottle" leg)

— Temperature: mildly warm at most; not the marked heat of cellulitis

— Venous ulcers at medial malleolus support the diagnosis

— Elevate to 45° for 1–2 minutes

— Stasis dermatitis erythema fades; cellulitis does not

Cellulitis exam:

Stasis dermatitis exam:

Bedside test — elevate the leg:

Board pearl: Hemosiderin staining + bilateral involvement + pitting edema + medial malleolar distribution = stasis dermatitis. Unilateral + fever + sharp tender margin + portal of entry = cellulitis.

Step 3 management: Document ABI before prescribing compression — compression with ABI <0.5 can cause ischemic injury; ABI 0.5–0.8 requires modified compression.

Key distinction: Erysipelas has a raised, sharply demarcated border and high fever; cellulitis has a flat, ill-defined border and more gradual onset.

Diagnostic Workup — Initial Labs, Imaging, and Bedside Studies

— CBC: leukocytosis with left shift supports cellulitis; normal WBC favors stasis dermatitis

— CRP/ESR: elevated in cellulitis, usually normal/mildly elevated in stasis dermatitis

— BMP, glucose: in diabetics or septic-appearing patients

— Lactate: if SIRS criteria met or necrotizing infection suspected

— Blood cultures: low yield (~5%); reserve for sepsis, immunocompromised, animal/water exposure, or treatment failure

— Wound/abscess cultures: sample purulent drainage if present; do not swab intact skin (yields colonizers)

— Ultrasound (POCUS): identifies occult abscess ("cobblestoning" of subcutaneous tissue with anechoic fluid pocket) — game-changer for "Does this need I&D?"

— Venous duplex: order if unilateral swelling to rule out DVT (a major mimic); also useful to confirm venous insufficiency in chronic cases

— Plain films: if foreign body, gas (necrotizing), or osteomyelitis suspected

— MRI: for suspected necrotizing fasciitis or osteomyelitis, but do not delay surgical consult for imaging in necrotizing infection

— ABI before compression

— Venous duplex to confirm venous reflux/incompetence

— Echo/BNP if bilateral edema with cardiac history (rule out CHF)

— Albumin, TSH, urinalysis if nephrotic/hypoalbuminemic edema suspected

Cellulitis is a clinical diagnosis — most uncomplicated cases need no labs or imaging. Order tests when systemic illness, diagnostic uncertainty, or treatment failure occurs.

Labs (when systemic signs present):

Imaging:

Stasis dermatitis workup:

CCS pearl: In a CCS case of unilateral red swollen leg, order venous duplex early — missing a DVT while treating "cellulitis" is a classic safety failure. If POCUS is available, look for abscess before committing to antibiotics alone vs I&D.

Board pearl: Procalcitonin is not validated to distinguish cellulitis from stasis dermatitis — don't pick it as the diagnostic answer.

Diagnostic Workup — Advanced and Confirmatory Studies

— Dermatology consult / e-consult: the single highest-yield intervention for suspected pseudocellulitis; reduces inappropriate antibiotics ~50% and admissions ~20%

— Skin biopsy: rarely needed acutely; reserved for atypical/refractory cases or to rule out cutaneous T-cell lymphoma, vasculitis, panniculitis, or pigmented purpuric dermatosis

— Stasis dermatitis biopsy shows dilated dermal capillaries, hemosiderin-laden macrophages, fibrosis, and eczematous changes — but biopsy is not routine

— Venous duplex with reflux study — confirms valvular incompetence (reflux >0.5 sec in superficial veins, >1.0 sec in deep)

— CEAP classification documents clinical severity (C0–C6); stasis dermatitis is C4a, ulceration is C5–C6

— Refer to vascular surgery for endovenous ablation in symptomatic reflux

— DVT: D-dimer + duplex (Wells score guides workup)

— Necrotizing fasciitis: LRINEC score ≥6 raises suspicion (CRP, WBC, Hgb, Na, Cr, glucose) — but it's a rule-in tool, not rule-out; surgical exploration is gold standard

— Contact dermatitis: patch testing if recurrent; neomycin, bacitracin, fragrances, lanolin are common stasis-area sensitizers

— Lipodermatosclerosis: clinical; chronic indurated, painful, hyperpigmented "bottle-shaped" calf — often misdiagnosed as cellulitis

When initial assessment is ambiguous:

Confirmatory venous workup (for chronic cases):

Ruling out alternative diagnoses:

Inflammatory markers in stasis dermatitis flares: mild CRP elevation can occur during acute eczematous flares — don't over-interpret as infection.

Key distinction: A patient with bilateral red legs, normal WBC, no fever, and improvement with elevation does not need blood cultures, MRI, or vancomycin — they need compression and a topical steroid.

Step 3 management: When stasis dermatitis is correctly identified, document ABI and venous duplex results in the chart before initiating compression — this protects against medicolegal risk if arterial disease is later found.

Risk Stratification and First-Line Management Logic

— Class I (mild): afebrile, no comorbidities, no systemic signs → outpatient oral antibiotics

— Class II (moderate): systemic signs OR comorbidity (DM, PVD, obesity) → outpatient PO if stable, observation unit, or short admission

— Class III: significant systemic illness or unstable comorbidities → admit

— Class IV: sepsis, necrotizing infection → ICU + surgical consult

— Nonpurulent cellulitis → β-hemolytic strep predominantly → cover strep (and MSSA): cephalexin or dicloxacillin

— Purulent (abscess, drainage, furuncle) → S. aureus, including MRSA → I&D + cover MRSA: TMP-SMX or doxycycline

— Severe purulent → IV vancomycin (or linezolid/daptomycin)

— Admit if: sepsis, hemodynamic instability, immunocompromise, failed outpatient therapy, inability to tolerate PO, rapidly progressing infection, suspected necrotizing infection, or unreliable follow-up

— Otherwise outpatient with 24–48 hour follow-up

— Foundation: compression therapy (20–30 or 30–40 mmHg gradient stockings) — contingent on ABI ≥0.8

— Leg elevation above heart level for 30 min, 3–4× daily

— Topical mid-potency corticosteroid (triamcinolone 0.1% ointment) BID for 2–4 weeks for acute flare

— Emollients (petrolatum) to repair barrier

— Treat underlying venous reflux with vascular referral if persistent

— Weight loss, smoking cessation, exercise

Cellulitis severity classification (Eron/IDSA-style):

Purulent vs nonpurulent (IDSA framework):

Outpatient vs inpatient:

Stasis dermatitis management logic:

Step 3 management: The single most evidence-based intervention for stasis dermatitis is graduated compression. Antibiotics have no role in stasis dermatitis.

Board pearl: Recurrent cellulitis (≥3 episodes/year) in patients with predisposing edema/lymphedema → consider prophylactic penicillin V 250 mg BID after addressing edema; reduces recurrence by ~50%.

Pharmacotherapy — First-Line Regimens

— Cephalexin 500 mg PO QID × 5–6 days (first-line)

— Dicloxacillin 500 mg PO QID (alternative)

— Penicillin allergy (non-severe): cefadroxil or cefuroxime

— Severe penicillin allergy: clindamycin 300–450 mg PO QID or doxycycline 100 mg BID

— 5 days is usually sufficient for uncomplicated cellulitis (DICE/CDC supported); extend to 10–14 days only if slow response

— I&D is primary therapy

— TMP-SMX DS 1–2 tabs BID or doxycycline 100 mg BID (covers MRSA)

— Add cephalexin if cellulitis surrounding abscess and concerned about strep coverage; TMP-SMX alone covers both MRSA and most strep at higher doses

— IV cefazolin 1–2 g q8h or ceftriaxone 1 g daily

— Severe penicillin allergy: clindamycin or vancomycin

— IV vancomycin (trough 15–20 or AUC-guided) — first-line MRSA

— Alternatives: linezolid, daptomycin, ceftaroline

— Topical triamcinolone 0.1% ointment BID × 2–4 weeks for acute eczematous flare

— Avoid topical antibiotics (neomycin, bacitracin) — high contact sensitization risk

— Antihistamines (sedating hydroxyzine at night) for pruritus

— Treat tinea pedis aggressively (topical terbinafine) — removes portal of entry for recurrent cellulitis

Nonpurulent cellulitis (outpatient, mild):

Purulent cellulitis / abscess (outpatient):

Inpatient nonpurulent cellulitis:

Inpatient purulent / severe / MRSA risk:

Stasis dermatitis pharmacotherapy:

Board pearl: Clindamycin covers MRSA and strep but has the highest C. diff risk of common cellulitis antibiotics — not first choice unless allergy mandates.

CCS pearl: When prescribing TMP-SMX in elderly or ACE-inhibitor/spironolactone users, recheck potassium and creatinine in 5–7 days — hyperkalemia is a common avoidable adverse event.

Key distinction: Steroids worsen cellulitis and antibiotics don't treat stasis dermatitis — getting the diagnosis right matters before reaching for the prescription pad.

Expanded Management — Procedures and Adjunctive Therapy

— Primary therapy for any abscess ≥2 cm or fluctuant collection

— Smaller abscesses in healthy hosts may resolve with I&D alone; adjunctive antibiotics improve cure rates (≈7% absolute benefit per RCTs) — give TMP-SMX or doxycycline

— Pack only if cavity is large; loop drainage is an alternative with less wound care burden

— Necrotizing fasciitis: emergent surgical debridement — outcomes depend on time to OR (<6 hours best); broad-spectrum antibiotics (vancomycin + piperacillin-tazobactam + clindamycin for toxin suppression) bridge to surgery

— Venous insufficiency: endovenous ablation (radiofrequency or laser), sclerotherapy, or stripping for refractory stasis dermatitis with documented reflux — reduces ulcer recurrence (EVRA trial)

— Multilayer compression bandages for active dermatitis/ulcer (Unna boot, four-layer wrap)

— Transition to graduated stockings 20–30 or 30–40 mmHg once skin stable

— Contraindications: ABI <0.5 (absolute), acute DVT, decompensated CHF, severe arterial disease

— Apply in morning before edema accumulates

— Complete decongestive therapy: manual lymphatic drainage, bandaging, exercise, skin care

— Skin care + treating tinea pedis prevents recurrent cellulitis

— Refer to certified lymphedema therapist

— Mark the erythema border with a pen to track progression — standard of care

— NSAIDs for pain (caution in renal disease, CHF)

— Tetanus update if wound-related

— Elevation of affected limb above heart accelerates resolution

Incision and drainage (I&D):

Surgical/vascular procedures for severe disease:

Compression therapy details (stasis dermatitis):

Lymphedema management (overlapping with cellulitis prevention):

Adjunctive measures for cellulitis:

Step 3 management: "Doesn't improve in 48 hours" → reassess for abscess (POCUS), MRSA, DVT, or wrong diagnosis (stasis dermatitis/gout/contact dermatitis) before broadening antibiotics. Reflex escalation without reassessment is a wrong-answer pattern.

Board pearl: Pentoxifylline is an evidence-based adjunct for venous ulcers but rarely tested first-line.

Special Populations — Elderly and Renal/Hepatic Impairment

— Higher baseline rates of chronic venous insufficiency, lymphedema, and stasis dermatitis — making "is this cellulitis or stasis dermatitis?" especially frequent

— Atypical presentations: delirium without fever may be the only sign of infection; lower threshold for labs

— Polypharmacy interactions: check warfarin (TMP-SMX, doxycycline, macrolides increase INR), statins, methotrexate (TMP-SMX → pancytopenia)

— Falls risk with sedating antihistamines — use non-sedating loratadine for pruritus in elderly

— Skin fragility means higher tape/wound dressing injury — use silicone-based dressings

— Cephalexin: reduce dose if CrCl <30 (250–500 mg q8–12h)

— TMP-SMX: reduce by 50% if CrCl 15–30; avoid if CrCl <15. Hyperkalemia risk amplified with ACEi/ARB/spironolactone — recheck K within 5–7 days

— Vancomycin: AUC-guided dosing (target AUC 400–600); avoid trough-only dosing per 2020 IDSA update; nephrotoxicity risk with concurrent piperacillin-tazobactam

— Clindamycin and doxycycline: no renal adjustment — safer choices in CKD

— Linezolid: safe in renal failure; watch for thrombocytopenia >14 days

— Doxycycline: generally safe but use cautiously in severe hepatic disease

— Linezolid: caution; reduce serotonergic drug exposure

— Avoid high-dose acetaminophen (>2 g/day) for cellulitis pain in cirrhosis

— Often have mixed arterial-venous disease — always check ABI before compression

— ABI 0.5–0.8: modified (reduced) compression only

— ABI <0.5: no compression; vascular referral

— Functional capacity to don/doff stockings is a real issue — consider Velcro wraps (CircAid)

Elderly considerations:

Renal impairment:

Hepatic impairment:

Compression in elderly:

Step 3 management: In a 78-year-old with bilateral red legs, edema, hemosiderin, and CHF: the answer is diuresis, compression after ABI check, topical steroid, and treat tinea pedis — not vancomycin.

Board pearl: Recurrent "cellulitis" in lymphedema after breast cancer = prophylactic penicillin candidate.

Special Populations — Pregnancy, Pediatrics, and Immunocompromised

— Cellulitis is more common due to physiologic edema and immune shifts

— Safe antibiotics: cephalexin, dicloxacillin, clindamycin (all category B equivalent)

— Avoid: doxycycline (tooth/bone), TMP-SMX (1st trimester neural tube defects; 3rd trimester kernicterus), fluoroquinolones

— Stasis dermatitis in pregnancy: compression stockings, elevation, topical low-mid potency steroid (triamcinolone 0.1% short courses are acceptable); avoid potent steroids on large areas

— Erythromycin estolate is contraindicated (hepatotoxicity); use base or ethylsuccinate

— Periorbital (preseptal) vs orbital cellulitis is the classic pediatric distinction — orbital cellulitis has proptosis, painful EOM, vision change → CT and IV antibiotics

— Buccal cellulitis in unvaccinated infants: consider Hib and pneumococcus

— Stasis dermatitis is uncommon in children — bilateral red legs in a child point to atopic dermatitis, contact dermatitis, viral exanthem, or vasculitis (HSP)

— Dosing: cephalexin 25–50 mg/kg/day divided QID; clindamycin 30–40 mg/kg/day divided

— Higher cellulitis risk and worse outcomes; always inspect feet for ulcers and web-space tinea

— Diabetic foot infection has different microbiology (polymicrobial including anaerobes) and may require amoxicillin-clavulanate or broader coverage

— Optimize glycemic control during infection; expect transient hyperglycemia

— Broader differential: atypical mycobacteria, fungi (cryptococcus, fusarium), gram-negatives, Pseudomonas in neutropenia

— Lower threshold for admission, blood cultures, and biopsy

— Empiric coverage often includes pseudomonal coverage (cefepime, piperacillin-tazobactam)

— High MRSA prevalence; cover MRSA empirically

— Screen for endocarditis (blood cultures, echo) if persistent bacteremia

— Consider deep abscess with POCUS

Pregnancy:

Pediatrics:

Diabetes:

Immunocompromised (HIV, transplant, neutropenia, chemo):

IV drug use:

Step 3 management: Pregnant patient with bilateral lower-leg erythema, normal vitals, varicosities: compression stockings + elevation, not antibiotics. Document fetal status and follow-up plan.

Complications and Adverse Outcomes

— Bacteremia and sepsis (~5% of admitted cellulitis cases)

— Abscess formation — re-examine and POCUS if not improving in 48–72 hours

— Necrotizing fasciitis — pain out of proportion, bullae, crepitus, anesthesia, rapid progression → surgical emergency, mortality 20–30% even with treatment

— Lymphangitis and lymphadenitis

— Osteomyelitis — bone involvement, especially in diabetic foot or chronic ulcer

— Endocarditis — particularly in IVDU or S. aureus bacteremia

— Recurrence — 30% within 3 years; each episode damages lymphatics, perpetuating cycle

— Post-streptococcal glomerulonephritis — rare; check UA if hematuria post-cellulitis

— Toxic shock syndrome — group A strep with shock and multi-organ involvement

— Venous ulceration (medial malleolus) — affects ~1% of adults, leading cause of chronic leg ulcers

— Lipodermatosclerosis — chronic fibrosis, "inverted champagne bottle" leg, painful

— Atrophie blanche — porcelain-white scars surrounded by telangiectasias

— Secondary infection (true cellulitis) — when stasis dermatitis breaks down skin, real infection can supervene → don't reflexively dismiss every red leg as stasis

— Contact dermatitis to topical agents (especially neomycin, bacitracin, fragrances) — autoeczematization

— Pigment changes — permanent hemosiderin staining

— C. difficile colitis — especially clindamycin, fluoroquinolones, broad-spectrum cephalosporins

— AKI with vancomycin or TMP-SMX

— Hyperkalemia with TMP-SMX + ACEi/ARB/spironolactone

— QT prolongation with fluoroquinolones, azithromycin

— Allergic reactions / SJS-TEN — especially TMP-SMX

Cellulitis complications:

Stasis dermatitis complications:

Antibiotic-related complications (highly tested):

Board pearl: A patient diagnosed with "cellulitis" who develops watery diarrhea 1 week after clindamycin → stool C. difficile PCR/toxin, start PO vancomycin or fidaxomicin, stop offending antibiotic.

Step 3 management: Failure to improve at 48–72 hours = reassess: (1) wrong diagnosis (stasis dermatitis, DVT, gout), (2) resistant organism (MRSA), (3) undrained abscess, (4) deeper infection (necrotizing, osteo).

When to Escalate Care — ICU, Consultation, and Inpatient Triage

— Systemic signs (fever, tachycardia, hypotension responsive to fluids)

— Failure of outpatient therapy after 48–72 hours

— Rapidly progressing erythema

— Immunocompromise, poorly controlled diabetes, severe PVD

— Inability to tolerate PO antibiotics

— Concern for deep/necrotizing infection pending workup

— Unreliable follow-up or homelessness

— Significant comorbidity (CHF decompensation, ESRD)

— Septic shock (lactate >2 with hypotension despite fluids, or requiring vasopressors)

— Necrotizing fasciitis — post-op ICU after debridement

— Multi-organ dysfunction

— Toxic shock syndrome

— Necrotizing soft-tissue infection — call surgery before imaging if high suspicion

— Large or deep abscess not amenable to bedside I&D

— Compartment syndrome concern

— Diabetic foot infection with concern for osteomyelitis or limb-threatening ischemia

— Infectious disease: recurrent cellulitis, unusual exposures (water, animal bites, immigration history), treatment failure, immunocompromise, MRSA bacteremia

— Dermatology: suspected pseudocellulitis, atypical rash, recurrent presentations — single highest-impact consult for misdiagnosis prevention

— Vascular surgery: documented venous reflux with refractory stasis dermatitis or ulcer; mixed arterial-venous disease

— Wound care: chronic venous ulcers

— Lymphedema therapy: post-mastectomy, congenital, or post-surgical lymphedema with recurrent cellulitis

Admit to hospital (ward):

ICU admission:

Surgical consultation (urgent):

Other specialist consults:

CCS pearl: In a CCS case suggesting necrotizing fasciitis (pain out of proportion, hypotension, rapidly spreading erythema, bullae), order in this sequence: (1) IV access + fluids, (2) blood cultures + labs + lactate, (3) broad-spectrum antibiotics (vanc + pip-tazo + clinda), (4) surgical consult STAT, (5) ICU admission. Do not wait for MRI before calling surgery.

Transitions of care: Document discharge criteria — afebrile 24h, tolerating PO, demarcated/regressing erythema, outpatient follow-up arranged within 48–72 hours.

Step 3 management: Always confirm PO antibiotic affordability and ability to obtain before discharge — a $300 antibiotic the patient won't fill is a readmission waiting to happen.

Key Differentials — Same-Category (Skin/Soft-Tissue) Causes

— Superficial dermis + lymphatics, group A strep

— Sharply demarcated, raised, fiery red plaque, often facial or lower leg

— High fever, rapid onset

— Treat with penicillin (still highly susceptible)

— Pain out of proportion, systemic toxicity, bullae, crepitus, anesthesia, rapid spread

— Surgical emergency

— Fluctuant, purulent; I&D primary, antibiotics adjunctive

— Pruritus dominant, well-demarcated to area of contact, may have vesicles

— Common offenders on stasis-prone legs: neomycin, bacitracin, fragrances

— Treat with topical steroid + removal of offender

— Coin-shaped pruritic plaques, chronic, bilateral

— Topical steroid + emollient

— Chronic, indurated, painful, "inverted champagne bottle" calf

— Often misdiagnosed as cellulitis because of warmth and tenderness; bilateral and chronic

— Treat: compression, pentoxifylline, sometimes topical/short-course steroid

— Tender, red, deep nodules on shins, bilateral

— Associated with strep, IBD, sarcoid, drugs (OCPs, sulfonamides), TB

— Treat underlying cause; NSAIDs

— Single expanding annular lesion with central clearing (target/bull's-eye), endemic area, tick exposure

— Doxycycline 100 mg BID × 10–14 days

— Painful ulcer with violaceous undermined border, associated with IBD, RA

— Do NOT debride (pathergy worsens it); immunosuppression

— Vibrio vulnificus (saltwater, immunocompromised, cirrhosis — bullous lesions, sepsis): add doxycycline + ceftriaxone

— Aeromonas (freshwater)

— Pasteurella (cat/dog bite): amoxicillin-clavulanate

— Eikenella (human bite): amoxicillin-clavulanate

Erysipelas:

Necrotizing fasciitis:

Abscess/furuncle/carbuncle:

Contact dermatitis (allergic or irritant):

Atopic dermatitis / nummular eczema:

Lipodermatosclerosis:

Erythema nodosum:

Erythema migrans (Lyme):

Pyoderma gangrenosum:

Cellulitis mimics from animal/water exposure:

Key distinction: Bilateral, chronic, pruritic, hemosiderin = stasis dermatitis. Unilateral, acute, painful, fever, portal of entry = cellulitis. Sharp raised border + fever = erysipelas. Pain out of proportion + bullae = necrotizing fasciitis → OR.

Key Differentials — Other-Category Causes (Systemic Mimics)

— Unilateral leg swelling, pain, warmth — looks like cellulitis but erythema is usually less prominent and calf tenderness with Homans sign may be present

— Wells score + D-dimer + duplex US

— May coexist with cellulitis; always consider DVT in unilateral red leg

— Monoarticular (1st MTP, ankle, knee), exquisite tenderness, often with erythema extending beyond joint

— Tophi, prior episodes

— Arthrocentesis — negatively birefringent needle crystals (gout) vs positively birefringent rhomboid (pseudogout)

— Treat: NSAIDs, colchicine, intra-articular steroid

— Joint pain on passive motion, fever, effusion

— Joint aspiration before antibiotics; WBC >50,000 in synovial fluid

— Sudden calf swelling/pain after popliteal cyst rupture, "crescent sign" of ecchymosis at malleolus

— US confirms

— Bilateral pitting edema with red, weepy skin from chronic stretching — pseudocellulitis

— Treat underlying cause; diuresis improves

— Non-pitting, positive Stemmer sign (can't pinch skin at base of 2nd toe), brawny induration

— Predisposes to true cellulitis recurrences

— Recent new medication, fever, eosinophilia, organ involvement (DRESS)

— ESRD on dialysis, painful violaceous reticulated plaques progressing to necrosis

— Sodium thiosulfate, optimize Ca/Phos

— Inflammatory breast cancer (mistaken for breast cellulitis); carcinoma erysipeloides (cutaneous metastasis)

— Failure to respond to antibiotics → biopsy

— Linear, tender, palpable cord along superficial vein

— NSAIDs, warm compresses; rule out extension to deep system with US

Deep vein thrombosis (DVT):

Acute gout / pseudogout:

Septic arthritis:

Ruptured Baker's cyst:

Heart failure / hypoalbuminemia / nephrotic syndrome:

Lymphedema:

Drug reactions / DRESS / fixed drug eruption:

Calciphylaxis:

Cellulitis mimics from cancer:

Superficial thrombophlebitis:

Board pearl: When the "cellulitis" doesn't improve with appropriate antibiotics in 72 hours, the most common reasons are (1) stasis dermatitis, (2) DVT, (3) gout, (4) contact dermatitis — not antibiotic resistance.

Step 3 management: Always perform focused MSK exam in lower-extremity erythema — joint involvement reframes the diagnosis entirely.

Secondary Prevention and Long-Term Management

— Treat tinea pedis aggressively — interdigital fungal infection is the most common portal of entry; topical terbinafine or clotrimazole, keep web spaces dry

— Manage edema/lymphedema — compression, weight loss, exercise, lymphedema therapy

— Skin care — daily emollients, treat cracks/fissures, careful nail care

— Glycemic control in diabetes (A1c goal individualized, generally <8%)

— Weight loss — BMI reduction reduces cellulitis recurrence

— Antibiotic prophylaxis — for ≥3 episodes/year despite addressing modifiable risks: penicillin V 250 mg PO BID or erythromycin 250 mg BID (PATCH trials show ~50% reduction; benefit wanes after discontinuation)

— Lifelong compression stockings (20–30 or 30–40 mmHg) — donned in morning, removed at bedtime

— Daily leg elevation above heart, 30 min × 3–4/day

— Daily emollient (petrolatum, ceramide-based) — barrier repair

— Avoid topical sensitizers: neomycin, bacitracin, fragranced products, lanolin

— Weight loss, smoking cessation, regular walking to enhance calf-muscle pump

— Treat reflux — endovenous ablation reduces recurrence and ulceration (EVRA trial showed faster ulcer healing with early ablation)

— Pentoxifylline 400 mg TID — evidence for venous ulcer healing

— Maintenance low-potency topical steroid (hydrocortisone 2.5%) for flares; reserve mid-potency for acute episodes

— Refer for wound care if ulceration develops

— Tetanus update for wound-prone patients

— Pneumococcal and influenza vaccines for elderly/comorbid

— DM screening if obesity or recurrent infection

Cellulitis recurrence prevention:

Stasis dermatitis long-term plan:

Vaccinations and general preventive care:

Board pearl: In recurrent cellulitis, the highest-yield intervention is identifying and treating the portal of entry — most often tinea pedis — not switching antibiotics.

Step 3 management: Discharge bundle after cellulitis: (1) antibiotic completion plan, (2) follow-up in 48–72h, (3) tinea pedis treatment, (4) edema management plan, (5) pen-and-paper marking instructions for the patient to track spread, (6) return precautions for worsening symptoms.

Follow-Up, Monitoring, and Counseling

— 48–72 hours post-diagnosis: clinical reassessment (in-person, telehealth, or nursing call) — expect erythema to stop spreading within 24–48h and start regressing by 72h

— End of course: skin should be near-resolved; some post-inflammatory hyperpigmentation acceptable

— Documentation: mark erythema borders with skin marker at index visit; photograph if possible

— Red flags for return: fever, spreading erythema, increased pain, new bullae, vomiting, confusion

— 2–4 weeks for response to compression and topical steroid

— 3–6 months for venous duplex review and consideration of intervention

— Annual vascular check, skin assessment for ulceration, weight/BMI tracking

— Antibiotic-related: renal function, INR (warfarin), potassium (TMP-SMX + ACEi)

— Compression efficacy: edema reduction, pain, ulcer healing

— Topical steroid duration: limit potent steroids to 2–4 weeks on lower legs; monitor for skin atrophy, striae, telangiectasia

— Diabetes: foot inspection at every visit

— Mark the border with pen and call if it expands beyond mark

— Elevation matters — above heart level

— Stockings on first thing in morning before swelling sets in

— Treat athlete's foot between toes — your "cellulitis" comes from there

— Moisturize daily to prevent skin cracking

— Don't use neomycin/bacitracin ointments — they cause allergy in stasis skin

— Complete the full antibiotic course even if better

— No "leftover" antibiotics for next episode — get reassessed

— Walking program (calf pump activation), ankle ROM exercises

— Weight loss referral

— Smoking cessation

— Lymphedema therapy if relevant

Cellulitis follow-up cadence:

Stasis dermatitis follow-up cadence:

Monitoring parameters:

Patient counseling — high-yield teaching points:

Rehab and lifestyle:

Step 3 management: Schedule a 48–72 hour follow-up for any outpatient cellulitis — early identification of treatment failure prevents admission. For stasis dermatitis, schedule a 2-week check to confirm response to compression and steroid before assuming chronic non-adherence.

Board pearl: Patient-marked erythema borders are a safety and quality standard that often appears in test questions about transitions of care.

Ethical, Legal, and Patient Safety Considerations

— Inappropriate antibiotics for stasis dermatitis drive C. difficile, antibiotic resistance, AKI, hyperkalemia, and allergic reactions

— National stewardship initiatives target "cellulitis" as a high-yield diagnosis for reduction because of high pseudocellulitis rates

— Document clear clinical reasoning in the chart when prescribing — or when withholding — antibiotics

— Discuss antibiotic risks (C. diff, allergic reactions, drug interactions) when prescribing

— For prophylactic penicillin in recurrent cellulitis: discuss lifetime risk-benefit, duration uncertainty, and that benefit wanes after stopping (PATCH II data) — true SDM moment

— Compression therapy in elderly: discuss risk of arterial compromise if ABI uncertain; document ABI before prescribing

— Discharging "cellulitis" without arranging 48–72 hour follow-up is a documented failure mode → readmissions

— Medication reconciliation: check for drug interactions with antibiotics (warfarin + TMP-SMX → bleeding; methotrexate + TMP-SMX → pancytopenia; statins + macrolides → rhabdo)

— Communicate clearly with primary care: diagnosis, treatment, follow-up plan, pending cultures

— Verify insurance coverage and pharmacy accessibility — uncovered antibiotics are a non-adherence risk

— Animal bites: report per local public health statutes (rabies risk assessment)

— Human bites: assess for abuse (domestic violence, child abuse) — mandatory reporting per state law

— Necrotizing infection: notify infection control; some states track GAS clusters

— IV drug use–related cellulitis: connect to harm reduction and MOUD (medications for opioid use disorder) — missed opportunity if not addressed

— Compression stockings often not covered without venous ulcer documentation — be explicit in coding (e.g., I83.1 venous insufficiency with inflammation)

— Lymphedema therapy access is inequitable — advocate for referral and document medical necessity

Antibiotic stewardship is a patient-safety imperative:

Informed consent and shared decision-making:

Transition-of-care safety (high-yield Step 3):

Mandatory reporting and special situations:

Health equity and access:

Step 3 management: Before discharging a patient with recurrent cellulitis, the safest, most board-favored action is a structured discharge bundle — antibiotic plan, tinea pedis treatment, compression prescription with ABI documentation, 48–72h follow-up, and patient education on red flags.

High-Yield Associations and Rapid-Fire Clinical Facts

— Most common pathogen in nonpurulent cellulitis: β-hemolytic streptococci (GAS)

— Most common pathogen in purulent cellulitis: S. aureus (often MRSA in US)

— Most common portal of entry: tinea pedis

— Single biggest risk factor for recurrence: chronic edema/lymphedema

— Periorbital vs orbital cellulitis: orbital has proptosis, painful EOM, vision change → CT + IV antibiotics + ENT consult

— Vibrio vulnificus: saltwater exposure + cirrhosis + bullous lesions → doxy + ceftriaxone

— Pasteurella: cat bite, rapid onset → amoxicillin-clavulanate

— Eikenella: human bite, clenched fist injury → amoxicillin-clavulanate; never close primarily

— Erysipelothrix: fish handler, gardener

— Aeromonas: freshwater, leeches

— LRINEC ≥6: consider necrotizing fasciitis

— 5 days = standard duration for uncomplicated cellulitis

— Distribution: medial malleolus and gaiter area, bilateral

— Hemosiderin staining = pathognomonic clue

— Atrophie blanche, lipodermatosclerosis, venous ulcer — all components of chronic venous disease spectrum

— CEAP C4a = stasis dermatitis; C5 = healed ulcer; C6 = active ulcer

— Compression is the cornerstone of therapy

— Check ABI before compression (≥0.8 full compression; 0.5–0.8 modified; <0.5 none)

— Avoid neomycin/bacitracin on stasis skin — high sensitization rate

— Triamcinolone 0.1% ointment = workhorse topical steroid for flares

— Endovenous ablation for documented reflux

— Pentoxifylline for venous ulcer adjunct

— Bilateral + chronic + pruritic + hemosiderin = stasis dermatitis

— Unilateral + acute + painful + fever + portal of entry = cellulitis

— Improves with elevation = stasis dermatitis

— Pain out of proportion + bullae = necrotizing fasciitis

— Sharp raised border + high fever = erysipelas

— Joint involvement = gout/septic arthritis

— Calf swelling + unilateral + risk factors = DVT

Cellulitis pearls:

Stasis dermatitis pearls:

Distinguishing rapid-fire:

Board pearl: When a question gives you bilateral red, scaly, itchy legs with edema and hemosiderin in an obese older adult, the answer is compression and topical steroid, not antibiotics — every time.

Board Question Stem Patterns

— "A 68-year-old obese woman with CHF and varicose veins presents with bilateral lower-leg erythema, scaling, and pruritus for 3 months. She has been treated with multiple courses of cephalexin without improvement. Exam shows hyperpigmented brown patches over the medial malleoli with pitting edema. Vitals normal. WBC 8,000. What is the most appropriate next step?"

— Answer: Compression stockings + topical triamcinolone + leg elevation (after ABI). Wrong answers: vancomycin, broader antibiotics, blood cultures.

— "A 55-year-old man with diabetes presents with 2 days of unilateral right leg redness, warmth, fever 38.5°C, and tenderness. Exam shows ill-defined erythema from ankle to mid-calf with maceration and scaling between the toes. WBC 14,500."

— Answer: Cephalexin PO + treat tinea pedis + mark borders + 48h follow-up.

— "Pain out of proportion to exam, rapidly spreading erythema, hypotension, lactate 4.5, hemorrhagic bullae, anesthesia over lesion."

— Answer: Emergent surgical debridement; do not delay for imaging. Antibiotics: vancomycin + piperacillin-tazobactam + clindamycin.

— Unilateral leg swelling and warmth after a long flight or recent surgery; mild erythema. Answer: venous duplex, not antibiotics.

— Four episodes in 12 months in a patient with chronic lymphedema; what reduces recurrence?

— Answer: Prophylactic penicillin V 250 mg BID after addressing edema and tinea pedis.

— Child with eyelid erythema → if EOM painful, proptosis, or vision change → orbital (CT, IV antibiotics, ENT). Otherwise preseptal (PO antibiotics).

— Elderly diabetic with bilateral leg redness; ABI 0.4. Answer: Do not apply compression; vascular consult.

— "Despite 72 hours of IV cefazolin, the bilateral erythema has not improved; patient is afebrile with normal WBC throughout." Answer: Reconsider diagnosis — stasis dermatitis; stop antibiotics, start compression and topical steroid.

Classic stasis dermatitis stem:

Classic cellulitis stem:

Necrotizing fasciitis stem:

DVT trap stem:

Recurrent cellulitis prevention stem:

Periorbital vs orbital cellulitis stem:

Compression contraindication stem:

Pseudocellulitis as treatment failure stem:

Step 3 management: Step 3 stems reward you for stopping the antibiotic and switching to compression/steroid when the picture is wrong for infection — even after another clinician has started antibiotics. Don't anchor on the prior diagnosis.

Board pearl: Look for "bilateral," "chronic," "afebrile," "normal WBC," "hemosiderin," "improves with elevation" — these are the magic words for stasis dermatitis.

One-Line Recap

Bilateral, chronic, pruritic, hemosiderin-stained lower-leg erythema with edema and no systemic illness is stasis dermatitis — treat with compression, elevation, and topical steroids; reserve antibiotics for unilateral, acute, painful, febrile cellulitis with an identifiable portal of entry.

— Cellulitis = unilateral, acute, painful, febrile, leukocytosis, portal of entry (often tinea pedis), responds to cephalexin (nonpurulent) or TMP-SMX/doxy (purulent/MRSA); duration 5 days for uncomplicated cases.

— Stasis dermatitis = bilateral, chronic, pruritic, hemosiderin staining, medial malleolar predominance, normal vitals, improves with elevation; treated with graduated compression (after ABI ≥0.8), leg elevation, topical mid-potency steroids (triamcinolone 0.1%), and treatment of underlying venous reflux.

— Always reassess at 48–72 hours when "cellulitis" doesn't improve — the answer is usually pseudocellulitis (stasis dermatitis, DVT, gout, contact dermatitis), not antibiotic resistance; stopping antibiotics and pivoting to compression/steroid is the board-favored move.

— Recurrent cellulitis prevention hinges on treating the portal of entry (tinea pedis) and managing edema/lymphedema before considering prophylactic penicillin V 250 mg BID; recurrent stasis dermatitis prevention hinges on lifelong compression, weight loss, and addressing venous reflux with endovenous ablation when indicated.

High-yield recap bullets:

Step 3 management: The single most important Step 3 decision in lower-leg erythema is distinguishing infection from inflammation — because the right answer is opposite in every domain: antibiotics vs steroids, unilateral vs bilateral, acute vs chronic, admit vs ambulatory compression clinic.

Board pearl: When in doubt, mark the border, elevate the leg, and look at the other leg — three bedside maneuvers that solve most "is this cellulitis?" questions on the wards and on the exam.